PressAt
Monday 2 June, 2025
Grünenthal announces that it agreed to acquire the commercial rights to Cialis®
from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal’s footprint in Latin America. As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile…
Read More
Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia
Monday 2 June, 2025 Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal’s footprint in Latin America. As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile…